Details
Stereochemistry | RACEMIC |
Molecular Formula | C23H36N4O5S3.ClH |
Molecular Weight | 581.212 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC(=O)CCCCC(CCSS\C(CCO)=C(\C)N(CC1=C(N)N=C(C)N=C1)C=O)SC(C)=O
InChI
InChIKey=NXYSZSRWHYVNSH-PLMZOXRSSA-N
InChI=1S/C23H36N4O5S3.ClH/c1-16(27(15-29)14-19-13-25-17(2)26-23(19)24)21(9-11-28)35-33-12-10-20(34-18(3)30)7-5-6-8-22(31)32-4;/h13,15,20,28H,5-12,14H2,1-4H3,(H2,24,25,26);1H/b21-16-;
DescriptionSources: http://drug-info.in/neuvita-octotiamine-fujisawa/
Sources: http://drug-info.in/neuvita-octotiamine-fujisawa/
Octotiamine is an analogue of vitamin B1. As a component of vitamin complex used for the treatment of vitamin B1 deficiency; vitamin B1 supplement.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://drug-info.in/neuvita-octotiamine-fujisawa/
Unknown
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
EGG1E98G4Q
Created by
admin on Sat Dec 16 10:00:50 GMT 2023 , Edited by admin on Sat Dec 16 10:00:50 GMT 2023
|
PRIMARY | |||
|
1181-74-4
Created by
admin on Sat Dec 16 10:00:50 GMT 2023 , Edited by admin on Sat Dec 16 10:00:50 GMT 2023
|
PRIMARY | |||
|
86278117
Created by
admin on Sat Dec 16 10:00:50 GMT 2023 , Edited by admin on Sat Dec 16 10:00:50 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD